Merrill Cuts HCA Outlook

Analyst A.J. Rice says his actions reflect HCA's expectations for a higher level of bad debt expense

Merrill Lynch cut its estimate on HCA (HCA ), and keeps the buy rating.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.